✦ LIBER ✦

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial

✍ Scribed by Hiroyuki Konaka, Shin Egawa, Shiro Saito, Atsunori Yorozu, Hiroyuki Takahashi, Keiko Miyakoda, Masanori Fukushima, Takushi Dokiya, Hidetoshi Yamanaka, Nelson N Stone, Mikio Namiki

Book ID: 119897198
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 240 KB
Volume: 12
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RTOG Protocol 05-18: A Phase III Randomi

RTOG Protocol 05-18: A Phase III Randomized Trial to Evaluate the Efficacy of Zoledronic Acid for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy (RT) and Long-term Luteinizing Hormone-releasing Hormone (LHRH) Agonist for High-grade and/or Locally Advanced Prostate Cancer

✍ Lawton, C.A.; Shook, S.; Smith, M.; Tripp, P.; Shah, A.B.; Martin, A.; Kim, H.E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB